Complete remission of refractory, ulcerated, primary cutaneous CD30+ anaplastic large cell lymphoma following brentuximab vedotin therapy

Complete remission of refractory, ulcerated, primary cutaneous CD30+ anaplastic large cell lymphoma following brentuximab vedotin therapy

Saved in:
Bibliographic Details
Published in:Acta dermato-venereologica Vol. 95; no. 2; pp. 233 - 234
Main Authors: Patsinakidis, Nikolaos, Kreuter, Alexander, Moritz, Rose K C, Stücker, Markus, Altmeyer, Peter, Möllenhoff, Katrin
Format: Journal Article
Language:English
Published: Sweden 01-01-2015
Subjects:
Antineoplastic Agents - therapeutic use
Biomarkers, Tumor - analysis
Biopsy
Humans
Immunoconjugates - therapeutic use
Immunohistochemistry
Ki-1 Antigen - analysis
Lymphoma, Large-Cell, Anaplastic - drug therapy
Lymphoma, Large-Cell, Anaplastic - immunology
Lymphoma, Large-Cell, Anaplastic - pathology
Male
Middle Aged
Remission Induction
Skin Neoplasms - drug therapy
Skin Neoplasms - immunology
Skin Neoplasms - pathology
Skin Ulcer - drug therapy
Skin Ulcer - immunology
Skin Ulcer - pathology
Time Factors
Treatment Outcome
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0001-5555
1651-2057
DOI:10.2340/00015555-1874